ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5,1,Headache,Headaches NEC,Headaches,Nerv,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
8,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
12,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
13,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
14,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
14,2,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
15,1,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
16,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
17,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
17,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
17,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
17,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
17,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
18,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
18,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
18,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
19,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
19,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
20,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
21,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
21,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
21,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
22,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
24,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
24,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
24,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
24,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
25,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
25,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,3,Ovarian hyperstimulation syndrome,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
26,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
26,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
26,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
26,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
27,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Anti-Muellerian hormone level decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
28,3,Headache,Headaches NEC,Headaches,Nerv,N
28,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
28,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
28,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
28,7,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
28,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,1,Premature ovulation,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Premature ovulation,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
32,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
33,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
33,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
34,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
34,2,Headache,Headaches NEC,Headaches,Nerv,N
34,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
35,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
35,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
